Literature DB >> 23707370

Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.

J S B Willson1, T D Godwin, G A R Wiggins, P J Guilford, J L McCall.   

Abstract

Maturity onset diabetes of the young type 3 (MODY3) and hepatocellular adenomas (HCAs) are associated with mutations in the HNF1A gene. HNF1A codes for the transcription factor HNF1α, which interacts with DNA as a homodimer or a heterodimer with HNF1β, to regulate multiple cellular functions including glucidic metabolism, lipidic transport, and detoxication. We report three members of one family with a novel germline in-frame deletion of HNF1A exons 2-3 identified initially using array CGH and direct sequence analysis. All three family members have MODY3 in association with primary liver cell tumours (HCA, liver adenomatosis (LA), and hepatocellular carcinoma (HCC)). Additionally, a high rate of infant mortality was observed in the family. The described family demonstrates a novel HNF1A mutation associated with both benign and malignant primary liver cell tumours and MODY3.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes; HNF1A; Hepatocellular adenoma; Hepatocellular carcinoma; MODY3

Mesh:

Substances:

Year:  2013        PMID: 23707370     DOI: 10.1016/j.jhep.2013.05.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.

Authors:  Jaclyn F Hechtman; Ghassan K Abou-Alfa; Zsofia K Stadler; Diana L Mandelker; Michael H A Roehrl; Ahmet Zehir; Efsevia Vakiani; Sumit Middha; David S Klimstra; Jinru Shia
Journal:  Hum Pathol       Date:  2018-08-17       Impact factor: 3.466

2.  Identifying gene disruptions in novel balanced de novo constitutional translocations in childhood cancer patients by whole-genome sequencing.

Authors:  Deborah I Ritter; Katherine Haines; Hannah Cheung; Caleb F Davis; Ching C Lau; Jonathan S Berg; Chester W Brown; Patrick A Thompson; Richard Gibbs; David A Wheeler; Sharon E Plon
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

Review 3.  Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.

Authors:  Xue Sun; Weihui Yu; Cheng Hu
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

Review 4.  Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis.

Authors:  Diane Goltz; Hans-Peter Fischer
Journal:  Int J Mol Sci       Date:  2015-09-02       Impact factor: 5.923

5.  Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach.

Authors:  Sneha P; Thirumal Kumar D; George Priya Doss C; Siva R; Hatem Zayed
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

Review 6.  Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.

Authors:  Elan Hahn; Juan Putra
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

7.  A multicentre retrospective analysis on growth of residual hepatocellular adenoma after resection.

Authors:  Anne J Klompenhouwer; Belle V van Rosmalen; Martijn P D Haring; Maarten G J Thomeer; Michail Doukas; Joanne Verheij; Vincent E de Meijer; Thomas M van Gulik; Robert B Takkenberg; Geert Kazemier; Frederik Nevens; Robert A de Man; Jan N M Ijzermans
Journal:  Liver Int       Date:  2020-04-28       Impact factor: 5.828

8.  Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes.

Authors:  Xiuting Huang; Siqian Gong; Yumin Ma; Xiaoling Cai; Lingli Zhou; Yingying Luo; Meng Li; Wei Liu; Simin Zhang; Xiuying Zhang; Qian Ren; Yu Zhu; Xianghai Zhou; Rui Zhang; Ling Chen; Xueying Gao; Fang Zhang; Yanai Wang; Xueyao Han; Linong Ji
Journal:  J Diabetes Res       Date:  2018-08-01       Impact factor: 4.011

9.  Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study.

Authors:  Keyue Ding; Songfeng Wu; Wantao Ying; Qi Pan; Xiaoyuan Li; Dachun Zhao; Xianyu Li; Qing Zhao; Yunping Zhu; Hong Ren; Xiaohong Qian
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

10.  Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3.

Authors:  Mengdie Hu; Xiuting Huang; Xueyao Han; Linong Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-02       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.